NSLI
BIIB icon

Nan Shan Life Insurance’s Biogen BIIB Stock Holding History

Nan Shan Life Insurance’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,000
Closed -$2.21M – 106
2020
Q1 		$2.21M Hold
7,000
– – 0.08% 84
2019
Q4 		$2.08M Buy
+7,000
New +$1.94M 0.06% 81
2016
Q3 		– Sell
-52,800
Closed -$12.8M – 76
2016
Q2 		$12.8M Hold
52,800
– – 0.49% 36
2016
Q1 		$13.7M Hold
52,800
– – 0.6% 38
2015
Q4 		$16.2M Hold
52,800
– – 0.93% 25
2015
Q3 		$15.4M Buy
52,800
+10,000
+23% +$3.3M 0.85% 29
2015
Q2 		$17.3M Buy
+42,800
New +$17.2M 0.93% 41

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nan Shan Life Insurance's BIIB Position: Q2 2020 in Review

Nan Shan Life Insurance sold out of Biogen (BIIB) in Q2 2020, closing a stake of 7,000 shares — an estimated $2.21M sold.

Nan Shan Life Insurance first reported a position in BIIB in Q2 2015 and held it in 7 quarters. The position peaked at $17.3M in Q2 2015. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Nan Shan Life Insurance reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Nan Shan Life Insurance sold 7,000 Biogen shares in Q2 2020, an estimated $2.21M.
  • Nan Shan Life Insurance first reported a position in Biogen in Q2 2015 and held it in 7 quarters.
  • Nan Shan Life Insurance's Biogen position peaked at $17.3M in Q2 2015.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Nan Shan Life Insurance's 13F filing for Q2 2020, filed 14 Aug 2020.